reports
KKR Completes Acquisition of PharMerica
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE:PMC) today announced the completion of the acquisition of PharMerica by a newly formed company controlled by KKR with an affiliate of Walgreens Boots Alliance, Inc. (Nasdaq: WBA) as a minority investor. As a result of the completion of the acquisition, PharMerica shareholders will receive an amount in cash equal to $29.25 per share of PharMerica common stock, without interest. In connection with the completion of the acquisition, shares of PharMerica’s common sto...
PharMerica Reports Third Quarter 2017 Results
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the third quarter ended September 30, 2017. Third Quarter 2017 Results The results for the third quarter of 2017 are set forth below: Key Comparisons of Third Quarters Ended September 30, 2017 and 2016: Revenues for the third quarter of 2017 were $595.1...
PharMerica Announces Approval of Merger by Stockholders
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), announced that at its special meeting of stockholders held today, a majority of the outstanding shares of PharMerica common stock voted to approve the adoption of the previously disclosed definitive merger agreement pursuant to which a newly formed company controlled by KKR, with Walgreens Boots Alliance, Inc. (Nasdaq: WBA) as a minority investor, will acquire PharMerica. The closing of the transaction remains subject to customary closing conditions. ...
PHARMERICA CORP. reduces its risk exposure and slightly improves to Ne...
The independent financial analyst theScreener just allocated a lower risk rating to PHARMERICA CORP. (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 3 out of 4 possible stars. Its market behaviour, however, has slightly improved and can be qualified as moderately risky. theScreener considers that these elements merit an overall rating upgrade to Neutral. As of the analysis date October 27, 2017, the closing price was USD 29.10 and i...
Onco360 Selected for VERZENIO® Limited Distribution Pharmacy Network
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Onco360, the nation’s largest independent Oncology Pharmacy, announced today that it has been selected to participate in the limited distribution network for Eli Lilly and Company’s new product, VERZENIOTM (Abemaciclib), a twice daily oral cyclin-dependent kinase (CDK) 4/6 inhibitor approved by the U.S. Food and Drug Administration (FDA). VERZENIO is used in combination with fulvestrant to treat women with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative advanc...
Bragar Eagel & Squire, P.C. Is Investigating the Board of Directors of...
NEW YORK--(BUSINESS WIRE)-- Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of PharMerica Corporation (NYSE: PMC) stockholders concerning the proposed acquisition of the company by KKR & Co. L.P. (NYSE: KKR) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA). The investigation concerns whether PharMerica Corporation’s board of directors failed to adequately shop the Company and obtain the best possible value for PharMerica stockholders before entering into a definitive merger agreement with KKR and Walgr...
PHARMERICA CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Annou...
WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of PharMerica Corporation (NYSE: PMC)? Did you purchase any of your shares prior to August 2, 2017? Do you think the proposed buyout is fair? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of PharMerica Corporation (“PharMerica” or the “Company”) (NYSE: PMC) regarding...
PHARMERICA CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie B...
DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of PharMerica Corporation (“PharMerica”) (NYSE: PMC) concerning the acquisition by KKR & Co. L.P. Unit. Under the terms of the agreement, valued at approximately $1.4 billion, PharMerica shareholders will only receive $29.25 per PharMerica share owned. The consideration is significantly lower than at least one analyst’s estimated value of $31.00. If y...
The Law Offices of Vincent Wong Notifies Investors of an Investigation...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of PharMerica Corporation (NYSE:PMC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to a newly formed company controlled by KKR, with minority investor Walgreens Boots Alliance, Inc. Under the terms of the deal, PharMerica shareholders will receive $29.25 in cash for each share of PharMerica stock they own. The investigation concerns whether the PharMerica B...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Inve...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased PharMerica Corporation (“PharMerica” or the "Company") (NYSE: PMC) stock prior to August 2, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of PharMerica to a newly formed company controlled by KKR, with minority investor Walgreens Boots Alliance, Inc. for $29.25 in cash per share. To learn more about the ac...
PharMerica Reports Second Quarter 2017 Results
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the second quarter ended June 30, 2017. ...
PharMerica Corporation Enters into Definitive Agreement to Be Acquired...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE:PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that it has entered into a definitive merger agreement pursuant to which a newly formed company controlled by KKR, with Walgreens Boots Alliance, Inc. (Nasdaq:WBA) as a minority investor, will acquire PharMerica. The all-cash transaction is valued at approximately $1.4 billion including the assumption or repayment of debt. Upon completion of t...
PharMerica Corporation Announces Second Quarter 2017 Earnings Call and...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE:PMC) announced today that it will provide an online webcast of its second quarter 2017 earnings conference call on Friday, August 4, 2017. The Company’s results for the second quarter ended June 30, 2017 will be released before the open of the market on Friday, August 4, 2017. The live broadcast of PharMerica’s conference call will begin at 10:00 a.m. Eastern Time on Friday, August 4, 2017. A 7-day online replay will be available beginning at 1:00 p.m. Eastern Ti...
PharMerica Reports First Quarter 2017 Results
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (the “Corporation”, PharMerica” or the “Company”) (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and specialty pharmacy services, today reported its financial results for the first quarter ended March 31, 2017. ...
PharMerica Corporation Announces First Quarter 2017 Earnings Call and ...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE:PMC) announced today that it will provide an online webcast of its first quarter 2017 earnings conference call on Wednesday, May 10, 2017. The Company’s results for the first quarter ended March 31, 2017 will be released before the open of the market on Wednesday, May 10, 2017. The live broadcast of PharMerica’s conference call will begin at 10:00 a.m. Eastern Time on Wednesday, May 10, 2017. A 7-day online replay will be available beginning at 1:00 p.m. Eastern ...
PharMerica Announces Date of 2017 Annual Meeting of Shareholders
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today announced that the Company’s 2017 annual meeting of shareholders will be held on Wednesday, June 14, 2017, in Louisville, Kentucky. Meeting details will be included in the Company’s 2017 proxy statement. Shareholders of record as of April 19, 2017, are entitled to vote at the meeting. About PharMerica PharMerica Corporation is a lea...
PharMerica Acquires CareMed Specialty Pharmacy
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE:PMC), a diversified national provider of institutional and specialty pharmacy services, announced today that it has completed the acquisition of CareMed Specialty Pharmacy (“CareMed”). Terms of the transaction were not disclosed. CareMed, based in New Hyde Park, NY, and licensed in all 50 states, provides comprehensive specialty pharmacy services nationally and is known industry-wide for its commitment to excellence and customer service. Greg Weis...
PharMerica Reports Fourth Quarter and Full Year 2016 Results
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (the “Corporation” or the “Company”) (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the fourth quarter and full year ended December 31, 2016. 4Q’16 Resul...
PharMerica Corporation Announces Fourth Quarter and Year End 2016 Earn...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE:PMC) announced today that it will provide an online webcast of its fourth quarter and year end 2016 earnings conference call on Friday, February 24, 2017. The Company’s results for the fourth quarter and year ended December 31, 2016 will be released before the open of the market on Friday, February 24, 2017. The live broadcast of PharMerica’s conference call will begin at 10:00 a.m. Eastern Time on Friday, February 24, 2017. A 7-day online replay will be availabl...
PharMerica Appoints Robert E. Dries as Executive Vice President and Ch...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced the appointment of Robert E. Dries as Executive Vice President and Chief Financial Officer, effective January 31, 2017. Mr. Dries brings to PharMerica more than 25 years of financial and operational experience and a deep knowledge of the pharmacy services industry. From 1996 to 2016, Mr. Dries held several senior positions at Omnicare Inc., m...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.